ING4 and pulmonary fibrosis: Tzouvelekis et al. [163] demonstrated, for the first time, the down-regulation of ING4 in a bleomycin (BLM)-induced model, and two different types of human pulmonary fibrosis, idiopathic pulmonary fibrosis (IPF) and cryptogenic organizing pneumonia (COP).